• No results found

[PDF] Top 20 Original Article Multikinase inhibitor in combination with chemotherapy in the treatment of advanced breast cancer-a meta-analysis

Has 10000 "Original Article Multikinase inhibitor in combination with chemotherapy in the treatment of advanced breast cancer-a meta-analysis" found on our website. Below are the top 20 most common "Original Article Multikinase inhibitor in combination with chemotherapy in the treatment of advanced breast cancer-a meta-analysis".

Original Article Multikinase inhibitor in combination with chemotherapy in the treatment of advanced breast cancer-a meta-analysis

Original Article Multikinase inhibitor in combination with chemotherapy in the treatment of advanced breast cancer-a meta-analysis

... of multikinase inhibitors to chemotherapy showed some activity in patients with ABC, the safety profile and toler- ability of this regimen present substantial chal- lenges to the further development, and ... See full document

10

A network meta-analysis on the efficacy of sixteen targeted drugs in combination with chemotherapy for treatment of advanced/metastatic colorectal cancer

A network meta-analysis on the efficacy of sixteen targeted drugs in combination with chemotherapy for treatment of advanced/metastatic colorectal cancer

... + chemotherapy, trebananib + chemotherapy and conatumumab + chemotherapy were more prominent among all the combined ...antibody-based treatment of cancer has been proved as one of the ... See full document

12

A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer

A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer

... indirect analysis’ that multiplied a pooled hazard ratio for chemotherapy versus endocrine therapy (from the meta-analysis by Wilken et ...in combination with TAM versus TAM (based on ... See full document

17

A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer

A network meta-analysis for toxicity of eight chemotherapy regimens in the treatment of metastatic/advanced breast cancer

... Two reviewers abstracted the data independently with the unified data collection form, and disagreements were resolved by discussion with a number of investigators. The trial size, trial design, details of intervention ... See full document

11

Chemotherapy plus dendritic cells co-cultured with cytokine- induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: A meta-analysis

Chemotherapy plus dendritic cells co-cultured with cytokine- induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: A meta-analysis

... CIKs treatment [13, ...as breast cancer, renal cell carcinoma, gastric cancer, colorectal cancer and leukemia [12, ...A meta-analysis of advanced NSCLC showed ... See full document

11

<p>Cinobufotalin as an effective adjuvant therapy for advanced gastric cancer: a meta-analysis of randomized controlled trials</p>

<p>Cinobufotalin as an effective adjuvant therapy for advanced gastric cancer: a meta-analysis of randomized controlled trials</p>

... 1,939 advanced GC patients were ...with chemotherapy alone, the combination of chemotherapy and cinobufotalin signi fi cantly improved patients' overall response rate (odds ratio [OR] ...after ... See full document

22

Original Article Clinical research on chemotherapy in combination with LMWH treatment of advanced lung cancer patients

Original Article Clinical research on chemotherapy in combination with LMWH treatment of advanced lung cancer patients

... with advanced lung cancer and gastrointestinal tumors ...anticoagulant treatment can inhibit invasion of tumor cells, and can extended survival time of patients when combine with chemotherapy ... See full document

10

Original Article Concurrent chemotherapy with or without nimotuzumab for treatment for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis

Original Article Concurrent chemotherapy with or without nimotuzumab for treatment for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis

... Nimotuzumab (NTZ) is a humanized monoclo- nal antibody (mAb). It competitively binds to the extra-cellular domain of the EGFR [18]. In previ- ous studies, NTZ was applied in various tumors, including the head and neck ... See full document

11

Original Article Clinic value of compound kushen injection combined with chemotherapy in breast cancer: a systematic review and meta-analysis

Original Article Clinic value of compound kushen injection combined with chemotherapy in breast cancer: a systematic review and meta-analysis

... of treatment, the studies were divided into two groups, (1) The course of the consecu- tive treatment of CKI exceeded 3 period (≥3C); (2) The course of the other trials were less than 3 period ...of ... See full document

15

Original Article An analysis of the chemotherapy efficacy on the survival of advanced gastric cancer patients

Original Article An analysis of the chemotherapy efficacy on the survival of advanced gastric cancer patients

... the chemotherapy effiacy in advanced gastric cancer patients and prognostic factors so that to provide a basis for improving the diagnosis and treatment of advanced gastric ... See full document

7

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review

... The multikinase inhibitor, sorafenib, has broad activity against tyrosine kinase receptors, including VEGFR and PDGFR, as well as angiogenic factors ...ovarian cancer or PPC who re- lapsed within 12 ... See full document

13

Original Article Clinical efficacy of bevacizumab combined with chemotherapy in the treatment of advanced non-squamous non-small cell lung cancer

Original Article Clinical efficacy of bevacizumab combined with chemotherapy in the treatment of advanced non-squamous non-small cell lung cancer

... the tumor development [6]. Inhibition of neo- vascularization has now become a great area of interest in scientific research. Blood vessels can disorder tissue structure and heterogene- ity, which may promote tumor ... See full document

9

Original Article Erlotinib versus chemotherapy (docetaxel/pemetrexed) as second-line therapy in advanced non-small cell lung cancer: a meta-analysis

Original Article Erlotinib versus chemotherapy (docetaxel/pemetrexed) as second-line therapy in advanced non-small cell lung cancer: a meta-analysis

... [9] Ng KP, Hillmer AM, Chuah CT, Juan WC, Ko TK, Teo AS, Ariyaratne PN, Takahashi N, Sawada K, Fei Y, Soh S, Lee WH, Huang JW, Allen JC Jr, Woo XY, Nagarajan N, Kumar V, Thalamuthu A, Poh WT, Ang AL, Mya HT, How GF, Yang ... See full document

12

The p53 breast cancer tissue biomarker in Indian women

The p53 breast cancer tissue biomarker in Indian women

... IHC analysis has been shown to be a prognostic factor for patients with breast cancer in ...of breast cancer, where it has also shown activity in tumors resistant to ...systemic ... See full document

8

Original Article Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy

Original Article Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy

... Against Cancer (UICC)/ American Joint Committee on Cancer ...of chemotherapy at least to evaluate treatment response according to RECIST ...of chemotherapy and the data of death from ... See full document

7

Original Article Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis

Original Article Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis

... prudent to pay attention to its weak estrogenic action on other tissues except for the breast, where it is antagonistic. It can stimulate the endometrium, resulting in an increased inci- dence of unscheduled ... See full document

11

Genomics and epidemiology for gastric adenocarcinomas

Genomics and epidemiology for gastric adenocarcinomas

... of breast cells, that the overexpression of only HER2 (which is also very important in GACs) in- duces dramatic proteome alterations in the ...with advanced disease, as previously ... See full document

9

A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers.

A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers.

... and combination therapy is almost inevitably necessary (26, ...(mTOR) inhibitor everolimus had modest clinical efficacy when used as a single agent in breast cancer ...in combination ... See full document

39

Prognostic value of CD44v6 expression in breast cancer: a meta-analysis

Prognostic value of CD44v6 expression in breast cancer: a meta-analysis

... that CD44v6 could help tumor cells escape the immune system to promote lymph node metastasis. Thus, our results are in line with those of basic studies. CD44v6 expression may be considered as a marker of breast ... See full document

7

&lt;em&gt;EGFR&lt;/em&gt; mutations as a prognostic and predictive marker in non-small-cell lung cancer

<em>EGFR</em> mutations as a prognostic and predictive marker in non-small-cell lung cancer

... domized Phase III study that included 1,217 patients with advanced lung adenocarcinoma from 87 clinical research cen- ters of nine Asian countries. The purpose of the study was to compare the efficiency of ... See full document

17

Show all 10000 documents...